<DOC>
	<DOCNO>NCT02006173</DOCNO>
	<brief_summary>This clinical trial double-blind , randomize , within-subject control , 2-armed , single-center study sponsor SciVision Biotech Inc. approve National Taiwan University Hospital Research Ethics Committee . The aim post-marketing study evaluate safety efficacy Hya-Dermis mixed lidocaine , well effectiveness correction Hya-Dermis mixed lidocaine . Accounting potential loss follow-up , minimum enrollment statistically determine 40 patient . The study estimate hold one half year include 0-2 week screen period , day treatment , follow-up month 1 , 3 , 6 , 9 , 12 . Patient informed consent form obtain treatment . A pre-treatment photograph , nasolabial fold ( NLF ) severity scale score , individual aesthetic satisfaction baseline . Two set randomize number use , patient number treatment number . Participants odd patient number assign nasolabial group even patient number assign nasolabial &amp; cheekbone group . Participants receive experiment treatment ( Hya-Dermis mixed lidocaine ) one side control treatment ( Hya-Dermis mixed normal saline ) side face randomly depend treatment number . Both physicians participant blind treatment assignment . 30 minute injection , post-photograph use evaluate NLF severity scale score global aesthetic improvement scale ( GAIS ) physicians . A questionnaire include Visual Analog Scale ( VAS ) pain treatment individual aesthetic satisfaction collect patient . The effectiveness analyse compare NLF severity scale score GAIS base photograph record physician , well participant questionnaire group every visit . The safety assessment evaluate recorded adverse event follow device treatment .</brief_summary>
	<brief_title>Safety Efficacy Study Lidocaine Mixed Hyaluronate Nasolabial Folds Correction</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Be 30 60 year age sex willing receive nasolabial fold correction intradermal injection procedure Have ability understand comply study requirement Have approximately symmetrical nasolabial fold nasolabial fold severity score 23 score difference two side less 1 Agree refrain undergo antiwrinkle treatment injective area 12 month injection . If female childbearing potential , breastfeeding , negative urine pregnancy test treatment day agree use approved contraceptive medically acceptable method birth control throughout study Be willing provide write informed consent prior procedure Have history active dermal disease , inflammation , related disease , infection , psoriasis , herpes . Have history coagulation defect diseases still take aspirin , anticlotting , blood activate medication 1 week treatment Had permanent semipermanent implantation nasolabial area Had dermalrelated surgery history ( example , laser , chemical dermabrasion , fraxel laser , thermocool ) 6 month treatment . Had facial wrinkle fold correction ( example , botox dermal filler ) 6 month study start Have know history allergic reaction like hypersensitivity hyaluronic acid Have know history allergic reaction lidocaine local anesthesia Have poor compliance study followup schedule</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Hya-Dermis mixed lidocaine reduce pain</keyword>
</DOC>